BioRestorative approves 1-for-20 reverse stock split to regain Nasdaq compliance

Verifying
  • BioRestorative’s board approved a 1-for-20 reverse split of its common stock.
  • 27,622,556 shares outstanding are expected to become approximately 1,381,128 shares.
  • Trading begins September 8, 2026, after expected effectiveness on September 7.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.